American Express Declares Dividends on Series B and C Preferred Stock


(MENAFN- AETOSWire) NEW YORK -Thursday 22 July 2021 [ AETOS Wire ]

(BUSINESS WIRE )-- American Express Company (NYSE: AXP) has declared the following dividends on the Company's Series B and C Preferred Shares:

  • A quarterly dividend on the Company's 5.200% Fixed Rate / Floating Rate Noncumulative Preferred Shares, Series B, of $9,059.25 per share (which is equivalent to $9.05925 per related Depositary Share). The dividend is payable on August 16, 2021, to shareholders of record on August 1, 2021.
  • A quarterly dividend on the Company's 4.900% Fixed Rate / Floating Rate Noncumulative Preferred Shares, Series C, of $8,698.80 per share (which is equivalent to $8.69880 per related Depositary Share). The dividend is payable on September 15, 2021, to shareholders of record on September 1, 2021.

ABOUT AMERICAN EXPRESS

American Express is a globally integrated payments company, providing customers with access to products, insights and experiences that enrich lives and build business success. Learn more at americanexpress.com and connect with us on facebook.com/americanexpress , instagram.com/americanexpress , linkedin.com/company/american-express , twitter.com/americanexpress , and youtube.com/americanexpress .

Key links to products, services and corporate responsibility information: charge and credit cards , business credit cards , travel services , gift cards , prepaid cards , merchant services , Accertify , InAuth , corporate card , business travel , and corporate responsibility .

Source: American Express Company
Location: Global

View source version on businesswire.com: 

MENAFN22072021004146001356ID1102493923


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.